Literature DB >> 4039882

Effect of propranolol on left ventricular relaxation in hypertrophic cardiomyopathy: an echographic study.

C Bourmayan, A Razavi, C Fournier, J C Dussaule, J Baragan, A Gerbaux, J Gay.   

Abstract

Many authors have shown that hypertrophic cardiomyopathy (HCM) is often associated with diastolic abnormalities. The purpose of this study was to determine the effect of propranolol on left ventricular isovolumic relaxation time (IVRT) measured by echocardiography in 20 patients with hypertrophic cardiomyopathy under basal conditions and under increasing doses of propranolol (160 mg, 320 mg, and 480 mg per day) and in two control groups, 10 patients with aortic stenosis, and 10 normal subjects. IVRT was less than 50 msec in all normal subjects, while it was always above this limit in aortic stenosis (77 msec +/- 8, p less than 0.001), and in hypertrophic cardiomyopathy (94 msec +/- 19, p less than 0.001), with also a significant difference between these two last groups (p less than 0.01). Under increasing doses of propranolol, relaxation time often shortens gradually until 50 msec or less. These results show an improvement in left ventricular relaxation dependent on the propranolol dosage and often a normalization at high dosages.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4039882     DOI: 10.1016/0002-8703(85)90357-6

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  6 in total

Review 1.  Hypertrophic cardiomyopathy in 2013: Current speculations and future perspectives.

Authors:  Georgios K Efthimiadis; Efstathios D Pagourelias; Thomas Gossios; Thomas Zegkos
Journal:  World J Cardiol       Date:  2014-02-26

2.  Effect of propranolol upon protein and proteolytic synthesis activity in hypertrophic myocardium.

Authors:  B Kwiatkowska-Patzer; T Zalewska
Journal:  Basic Res Cardiol       Date:  1988 Jan-Feb       Impact factor: 17.165

3.  Beta-Blockers in Pediatric Hypertrophic Cardiomyopathies.

Authors:  Ingegerd Östman-Smith
Journal:  Rev Recent Clin Trials       Date:  2014

4.  Effects of lifestyle changes and high-dose β-blocker therapy on exercise capacity in children, adolescents, and young adults with hypertrophic cardiomyopathy.

Authors:  Ewa-Lena Bratt; Ingegerd Östman-Smith
Journal:  Cardiol Young       Date:  2014-03-10       Impact factor: 1.093

5.  Factors influencing long-term heart failure mortality in patients with obstructive hypertrophic cardiomyopathy in Western Sweden: probable dose-related protection from beta-blocker therapy.

Authors:  Davood Javidgonbadi; Bert Andersson; Nils-Johan Abdon; Maria Schaufelberger; Ingegerd Östman-Smith
Journal:  Open Heart       Date:  2019-06-27

6.  Intrauterine Treatment of a Fetus with Familial Hypertrophic Cardiomyopathy Secondary to MYH7 Mutation.

Authors:  Meghan G Hill; Mehtab K Sekhon; Kathryn L Reed; Caroline F Anderson; Nydia D Borjon; Jil C Tardiff; Brent J Barber
Journal:  Pediatr Cardiol       Date:  2015-09-04       Impact factor: 1.655

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.